Quinoxaline-incorporated Schiff bases (4a-j) were synthesized by the condensation of 2-[(3-methylquinoxalin-2-yl)oxy]acetohydrazide (3) with indole-3-carbaldehyde, furfuraldehyde, 5-(4-nitrophenyl)-2-furfuraldehyde, and substituted benzaldehydes under conventional and microwave irradiation methods. e microwave method was found to be remarkably successful with higher yields, less reaction time, and environmentally friendly compared to conventional heating method. e chemical structures of the synthesized compounds have been con�rmed by analytical and spectral data. All the compounds have been evaluated for antitubercular and anti-in�ammatory activities.
Introduction
Quinoxaline derivatives have been reported to possess a wide range of biological properties such as being anticancer [1, 2] , antihistaminic [3] , antiviral [4] , antimicrobial [5, 6] , antifungal [7] , antitubercular [8, 9] , and anti-in�ammatory [10] . Schiff bases possess antimicrobial [11] , antitubercular [12] , anti-in�ammatory [13] , and analgesic [14] properties. In view of these facts, we herein report the facile synthesis of a new series of quinoxaline-incorporated schiff bases and screen for antitubercular and anti-in�ammatory activities. In recent times, microwave-assisted organic reactions have become very popular and gain special attention due to their ecofriendly nature, safety, less reaction time, and higher yields. In continuation of our research on quinoxaline derivatives, in the present study, we made an attempt to synthesize the title compounds using conventional and microwave irradiation methods and compared the reaction time and percentage yields.
Experimental
Melting points were determined using open capillary tubes on ANALAB melting point apparatus and are uncorrected. IR spectra were recorded on FTIR spectrophotometer (SHI-MADZU 8400 series) using KBr pellets. 
ion peak at m/z 233 (100%) corresponding to its molecular weight in mass spectrum con�rmed the structure of the compound (3). From compound (3), ten different Schiff bases have been synthesized (Scheme 1) by condensing with indole-3-carbaldehyde, furfuraldehyde, 5-(4-nitrophenyl)-2-furfuraldehyde, and substituted benzaldehydes using conventional and microwave irradiation methods. e physical data of Schiff bases, time and yields in both the methods, were compared and mentioned in the Table 1 .
Antitubercular Activity.
All the newly synthesized compounds were evaluated for their possible in vitro antitubercular activity at a concentration of 6.25 g/mL against Mycobacterium tuberculosis H 37 RV (ATCC 27294) in BACTEC 12B medium using both micro dilution assay and the microplate alamar blue assay (MABA). Compounds exhibiting �uores-cence were tested in the BACTEC 460 radiometric system. e antitubercular activity data were compared with standard drug, Rifampin at a concentration of 0.25 g/mL. e compounds 4c, 4d, 4i, and 4j exhibited substantial antitubercular activity, particularly 4h showed 75% inhibition (MIC > 6.25 g/mL) and emerged as the most active compound in the present series. e MIC and percentage inhibition data of the compounds that have shown activity against Mycobacterium tuberculosis are presented in Table 2 .
3.�. Anti-�n�ammatory Activity.
Male Wistar rats (140-200 g) of both sexes were used for the studies. e rats were obtained from Mahaveer enterprises, Hyderabad. e animals were divided into groups of six each and fasted for 12 hr before the experiment. e ethical guidelines prescribed for the investigation of animals used in experiments were followed in all tests. Carrageenan (0.1 mL, 1%) was administered into the plantar surface of the right hind paw of each rat, 1 hr aer the administration of the test compounds and standard drug ibuprofen (100 mg/kg). One group was kept as control, received only 0.5% CMC solution. Before injection of carrageenan, the average volume ( ) of the right hind paw of each rat was calculated. Aer injection, the paw volume ( ) was measured aer 3rd hr with the aid of a plethysmograph. e edema was expressed as an increase in the volume of paw, and percentage inhibition of acute edema was obtained as follows:
where
Among all the compounds, compounds 4a, 4b, 4d, 4g, 4h and 4i exhibited signi�cant activity at 3rd hr (Table 3) . Results are presented as Mean ± SEM (standard error of mean) of six rats. Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Dunnett's test for multiple comparisons, using Graph-pad Soware. and 4i were administered orally in doses up to 2000 mg/kg and mice were kept under observation for period of 24 hrs.
General Procedure for the Synthesis of Schiff Bases

Microwave Irradiation Method. 2-[(3-Methylquinoxalin-2-yl)oxy]acetohydrazide (3)
(0.01 mole, 2.32 g) was dissolved in 10 mL of DMF and to this was added heterocyclic/aromatic aldehyde (0.01 mole) and few drops of glacial acetic acid. e mixture was transferred to a vessel and kept in the microwave oven. e oven was run at 400-480 W for different time for different reaction mixtures. e completion of the reaction was monitored continuously by TLC aer every minute. e product obtained was poured into water, �ltered, dried, and recrystallized from a mixture of DMF and water.
Conventional Method. Equimolar mixture of 2-[(3-methylquinoxalin-2-yl)oxy]acetohydrazide (3)
and appropriate heterocyclic/aromatic aldehyde was dissolved in 90% ethanol and to this was added catalytic amount of glacial acetic acid and re�uxed for 5-7 hr. Excess ethanol was removed under reduced pressure, and the residue was puri�ed by washing with cold ethanol and recrystallized from DMF and water mixture. 
Conclusion
A novel series of schiff bases were synthesized by using conventional and microwave irradiation methods and all the compounds were characterized by physical and spectral data. Compounds 4c, 4d, 4h, 4i, and 4j exhibited potent antitubercular activity. Compounds 4a, 4b, 4d, 4g, 4h, and 4i have shown signi�cant protection against the edema formation. �ith further molecular modi�cation and manipulation of these compounds, several other promising bioactive molecules can be developed in future.
